Patents by Inventor BEHAR

BEHAR has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12294666
    Abstract: According to various embodiments of the disclosure, an electronic device may include: a first housing, a second housing rotatably coupled with the first housing and configured to rotate between a first position at which the second housing at least partially faces the first housing and a second position at which the second housing is unfolded at a specified angle from the first position, a hinge module including a hinge providing at least one folding axis and rotatably coupling the first housing and the second housing about the folding axis, and a hinge cover disposed between the first housing and the second housing and coupled to surround at least a part of the hinge module, and at least one part of the hinge cover may be configured to be located closer to the hinge module at the second position than at the first position.
    Type: Grant
    Filed: April 29, 2022
    Date of Patent: May 6, 2025
    Assignee: Samsung Electronics Co., Ltd.
    Inventors: Junyong Song, Byoungjin Kim, Sejung Whang, Nakyoung Lee, Valentin Sollier, Yves Behar, Qin Li
  • Patent number: 12285083
    Abstract: Radial-armed thin-film bilayers are designed and fabricated from a metal and an oxide to produce grippers that interact with the yarns or fibers of the fabric and form a mechanical tangle attachment to the fabric. MEMs devices attached to the grippers enable the MEMs devices to be adhered to a flexible and/or extensible fabric. Fabrics comprise conventional textile, smart textiles, functional fibers or other smart materials. The fabrics thus incorporate wearable sensors, medical devices, and other functional MEMs for commercial, biomedical, industrial and scientific applications.
    Type: Grant
    Filed: August 3, 2020
    Date of Patent: April 29, 2025
    Assignee: University of Louisville Research Foundation, Inc.
    Inventors: Cindy K. Harnett, Jasmin Beharic, Canisha Barbara Ternival, Sushmita Challa, Mohammad Shafquatul Islam
  • Publication number: 20250086445
    Abstract: A convolutional neural network (CNN) accelerator, including: a CNN circuit for performing a multiple-layer CNN computation, wherein the multiple layers are to receive an input feature according to an input feature map (IFM) and a weight matrix per output feature, wherein an output of a first layer provides an input for a next layer; and a mapping circuit to access a three-dimensional input matrix stored as a Z-major matrix; wherein the CNN circuit is to perform an inner-product direct convolution on the Z-major matrix, wherein the direct convolution lacks a lowering operation.
    Type: Application
    Filed: September 18, 2024
    Publication date: March 13, 2025
    Applicant: Intel Corporation
    Inventors: Ehud Cohen, Moshe Maor, Ashutosh Parkhi, Michael Behar, Yaniv Fais
  • Publication number: 20250049703
    Abstract: The present invention relates to methods and pharmaceutical compositions for the treatment of retinal capillary non-perfusion. In particular, the present invention relates to a method of treating retinal capillary non-perfusion in a subject in need thereof comprising administering to the subject a therapeutically effective amount of a ROCK inhibitor.
    Type: Application
    Filed: June 13, 2024
    Publication date: February 13, 2025
    Inventors: Francine BEHAR-COHEN, Patricia CRISANTI-LASSIAZ
  • Patent number: 12223427
    Abstract: In an example, an apparatus comprises a plurality of execution units comprising and logic, at least partially including hardware logic, to receive a plurality of data inputs for training a neural network, wherein the data inputs comprise training data and weights inputs; represent the data inputs in a first form; and represent the weight inputs in a second form. Other embodiments are also disclosed and claimed.
    Type: Grant
    Filed: May 30, 2023
    Date of Patent: February 11, 2025
    Assignee: INTEL CORPORATION
    Inventors: Lev Faivishevsky, Tomer Bar-On, Yaniv Fais, Jacob Subag, Jeremie Dreyfuss, Amit Bleiweiss, Tomer Schwartz, Raanan Yonatan Yehezkel Rohekar, Michael Behar, Amitai Armon, Uzi Sarel
  • Patent number: 12217101
    Abstract: Methods, apparatus, systems and articles of manufacture are disclosed to configure heterogenous components in an accelerator. An example apparatus includes a graph compiler to identify a workload node in a workload and generate a selector for the workload node, and the selector to identify an input condition and an output condition of a compute building block, wherein the graph compiler is to, in response to obtaining the identified input condition and output condition from the selector, map the workload node to the compute building block.
    Type: Grant
    Filed: April 28, 2023
    Date of Patent: February 4, 2025
    Assignee: INTEL CORPORATION
    Inventors: Michael Behar, Moshe Maor, Ronen Gabbai, Roni Rosner, Zigi Walter, Oren Agam
  • Publication number: 20250025480
    Abstract: Methods and pharmaceutical compositions for the treatment of choroidal neovascularisation are provided. In particular, a method of treating choroidal neovascularisation in a subject in need thereof comprising administering to the subject a therapeutically effective amount of a mineralocorticoid receptor antagonist is provided.
    Type: Application
    Filed: July 29, 2024
    Publication date: January 23, 2025
    Inventors: Francine BEHAR-COHEN, Min ZHAO
  • Patent number: 12162868
    Abstract: The present invention relates to novel piperazine derivatives, methods for their preparation, pharmaceutical compositions including such compounds, and methods of using these compounds and compositions, especially for targeted therapy treatment of hyperproliferative disorders, including benign hyperproliferative disorders, cancer and pre-cancer conditions.
    Type: Grant
    Filed: August 8, 2021
    Date of Patent: December 10, 2024
    Assignee: Vidac Pharma Ltd..
    Inventors: Paul Salama, Vered Behar, Oren Menahem Becker
  • Patent number: 12147914
    Abstract: Embodiments described herein provide a processing apparatus comprising compute circuitry to generate neural network data for a convolutional neural network (CNN) and write the neural network data to a memory buffer. The compute circuitry additionally includes a direct memory access (DMA) controller including a hardware codec having encode circuitry and a decode circuitry. The DMA controller reads the neural network data from the memory buffer, encode the neural network data via the encode circuit, writes encoded neural network data to a memory device coupled with the processing apparatus, writes metadata for the encoded neural network data to the memory device coupled with the processing apparatus, and decodes encoded neural network data via the decode circuit in response to a request from the compute circuitry.
    Type: Grant
    Filed: September 14, 2023
    Date of Patent: November 19, 2024
    Assignee: Intel Corporation
    Inventors: Ajit Singh, Bharat Daga, Michael Behar
  • Publication number: 20240366632
    Abstract: Ocular Rosacea (OR) is a chronic inflammatory and neurovascular diseases of the ocular surface and eyelids. associated with abnormal tear film lipids that can lead to corneal neovascularization, loss of transparency and ulceration. Here, the inventors show that the combination of mineralocorticoid receptor blockade in association with local ocular glucocorticoids that have high GR binding affinity, have superior effects as compared to MR blockade alone, without the side effects of glucocorticoids on corneal wound healing. The combination of MR antagonist and low dose of a GR activator further reduces corneal edema, corneal neovascularization and improves corneal wound healing. The combination of MR antagonist and triamcinolone that has a strong GR binding affinity reinforces the beneficial effects of MR antagonists.
    Type: Application
    Filed: August 31, 2022
    Publication date: November 7, 2024
    Inventors: Francine BEHAR-COHEN, Min ZHAO
  • Patent number: 12131250
    Abstract: A convolutional neural network (CNN) accelerator, including: a CNN circuit for performing a multiple-layer CNN computation, wherein the multiple layers are to receive an input feature according to an input feature map (IFM) and a weight matrix per output feature, wherein an output of a first layer provides an input for a next layer; and a mapping circuit to access a three-dimensional input matrix stored as a Z-major matrix; wherein the CNN circuit is to perform an inner-product direct convolution on the Z-major matrix, wherein the direct convolution lacks a lowering operation.
    Type: Grant
    Filed: September 29, 2017
    Date of Patent: October 29, 2024
    Assignee: Intel Corporation
    Inventors: Ehud Cohen, Moshe Maor, Ashutosh Parkhi, Michael Behar, Yaniv Fais
  • Publication number: 20240350593
    Abstract: This invention relates to the treatment of macular edema. Macular edema is the main cause of vision loss during diabetic macular edema, wet AMD (Age Related Macular Degeneration), retinal vein occlusion and chronic intraocular inflammation. Currently, beyond photocoagulation by laser irradiation, two types of drugs are used, protein molecules that neutralize VEGF family members and glucocorticoids, with different mechanisms of action, but targeting one single symptom: macular edema. The inventors have now found that macular edema may be treated by increasing the oncotic pressure of the vitreous. According to the inventors' understanding, causing an increase in the oncotic pressure of the vitreous induces a liquid flow from the interstitial water accumulated in the retina tissue to the vitreous compartment, so as to reduce or stop macular edema.
    Type: Application
    Filed: March 29, 2024
    Publication date: October 24, 2024
    Inventors: Francine BEHAR-COHEN, Raphael COHEN, Rinath LEVY-BOUKRIS, Min ZHAO
  • Patent number: 12083111
    Abstract: The present invention provides methods of use of hexokinase 2 (HK2)/mitochondria-detaching compounds, including jasmonate derivatives and piperazine derivatives and pharmaceutical compositions including such compounds for inducing immune responses in a subject, including potentiating the immune response to hyperproliferative disorders such as cancer and potentiating the immune response to infectious diseases.
    Type: Grant
    Filed: August 17, 2021
    Date of Patent: September 10, 2024
    Assignee: Vidac Pharma Ltd ..
    Inventors: Vered Behar, Oren Menahem Becker, Reut Yosef Hamo, Eyal Dor-On
  • Publication number: 20240295902
    Abstract: A portable computer that is configurable between a plurality of display modes including a laptop mode (in which the portable computer has a conventional laptop appearance) and an easel mode in which the base of the computer and its display component stand vertically forming an inverted “V.” The portable computer includes a hinge assembly that couples the display component to the base of the computer, and allows the display component to be rotated about an axis along an interface between the display component and the base to configure the portable computer between a closed position, the laptop mode and the easel mode.
    Type: Application
    Filed: November 7, 2023
    Publication date: September 5, 2024
    Applicant: LiTL LLC
    Inventors: Yves Behar, Joshua Morenstein, Christopher Hibmacronan, Naoya Edahiro, Matthew David Day
  • Publication number: 20240295903
    Abstract: A portable computer that is configurable between a plurality of display modes including a laptop mode (in which the portable computer has a conventional laptop appearance) and an easel mode in which the base of the computer and its display component stand vertically forming an inverted “V.” The portable computer includes a hinge assembly that couples the display component to the base of the computer, and allows the display component to be rotated about an axis along an interface between the display component and the base to configure the portable computer between a closed position, the laptop mode and the easel mode.
    Type: Application
    Filed: May 8, 2024
    Publication date: September 5, 2024
    Applicant: LiTL LLC
    Inventors: Yves Behar, Joshua Morenstein, Christopher Hibmacronan, Naoya Edahiro, Matthew David Day
  • Publication number: 20240286769
    Abstract: A connection system is provided for releasably connecting a first component and a second component in a first direction parallel to a reference longitudinal axis, including one or more locking devices and an actuator. Each locking device has a geometrically locked configuration and an unlocked configuration. In the geometrically locked configuration the locking device is capable of reversibly geometrically locking together the first component and the second component in a mutually clamped relationship along the first direction, each locking device comprising at least two linkage elements pivotably mounted to one another about a common clamp axis. The actuator device is configured for transitioning each locking device from the geometrically locked configuration to the unlocked configuration by selectively applying to each respective locking device an unlocking force directly to the respective linkage elements at the respective common clamp axis, in a second direction parallel to a reference transverse axis.
    Type: Application
    Filed: June 15, 2022
    Publication date: August 29, 2024
    Inventors: Baruch BEHAR, Ziv GOLAN
  • Publication number: 20240289000
    Abstract: Various aspects and embodiments are directed to a graphical user interface that organizes interface elements into views of computer content for presentation to a user. Different views of are used to provide an interface that is responsive to configurations of the device and activities performed by the user. Aspects include permitting the user to transition the device from one configuration to another during its use. The elements that comprise the graphical user interface are configured to present a summarized view of available actions and content to simplify user interaction. The different views present different organizations of the interface elements and in some examples display only certain modes of content in order to reduce the number of options a user must navigate. Methods and systems for streamlining user interaction with computer content are also provided. Streamlining includes, for example, pre-configuring a user device based on received information.
    Type: Application
    Filed: May 8, 2024
    Publication date: August 29, 2024
    Applicant: LiTL LLC
    Inventors: Yves Behar, Joshua Morenstein, Christopher Hibmacronan, Naoya Edahiro, Matthew David Day, Robert Sanford Havoc Pennington, Noah Bruce Guyot, Daniel Kuo, Jenea Boshart Hayes, Aaron Tang, Donald Francis Fischer, Christian Marc Schmidt, Lisa Strausfeld, David Livingston Fore, John H. Chuang, Chris Bambacus, Bart Haney, Logan Ray, Serge Beaulieu
  • Patent number: 12048761
    Abstract: The present invention relates to methods and pharmaceutical compositions for the treatment of retinal capillary non-perfusion. In particular, the present invention relates to a method of treating retinal capillary non-perfusion in a subject in need thereof comprising administering to the subject a therapeutically effective amount of a ROCK inhibitor.
    Type: Grant
    Filed: October 12, 2016
    Date of Patent: July 30, 2024
    Assignees: INSERM (INSTITUT NATIONAL DE LA SANTÉ ET DE LA RECHERCHE MEDICALE), UNIVERSITÉ PARIS DESCARTES, UNIVERSITÉ PARIS DIDEROT—PARIS 7, FONDATION ASILE DES AVEUGLES, SORBONNE UNIVERSITÉ
    Inventors: Francine Behar-Cohen, Patricia Crisanti-Lassiaz
  • Patent number: 11986514
    Abstract: This invention relates to the treatment of macular edema. Macular edema is the main cause of vision loss during diabetic macular edema, wet AMD (Age Related Macular Degeneration), retinal vein occlusion and chronic intraocular inflammation. Currently, beyond photocoagulation by laser irradiation, two types of drugs are used, protein molecules that neutralize VEGF family members and glucocorticoids, with different mechanisms of action, but targeting one single symptom: macular edema. The inventors have now found that macular edema may be treated by increasing the oncotic pressure of the vitreous. According to the inventors' understanding, causing an increase in the oncotic pressure of the vitreous induces a liquid flow from the interstitial water accumulated in the retina tissue to the vitreous compartment, so as to reduce or stop macular edema.
    Type: Grant
    Filed: August 31, 2018
    Date of Patent: May 21, 2024
    Assignees: INSERM (INSTITUT NATIONAL DE LASANTE ET DE LA RECHERCHE MEDICALE), SORBONNE UNIVERSITE, UNIVERSITE DE PARIS, ASSISTANCE PUBLIQUE—HOPITAUX DE PARIS
    Inventors: Francine Behar-Cohen, Raphael Cohen, Rinath Levy-Boukris, Min Zhao
  • Patent number: D1064135
    Type: Grant
    Filed: February 5, 2020
    Date of Patent: February 25, 2025
    Assignee: Interactive Strength, Inc.
    Inventors: Yves Albert Behar, Trent Ward, William Stuart, Andrea Locatelli, Jón Reyr Jóhannesson, Karim El Katcha